Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...
Prediction: These Could Be the Best-Performing Fintech Stocks Through 2030
Motley Fool via Yahoo Finance· 8 hours agoThe COVID-19 pandemic only put a brighter spotlight on these other payment options, as much of the...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoBut the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not...
Wisconsin Supreme Court's liberal justices appear poised to flip ballot drop box ban
Wisconsin State Journal· 2 days agoThe state's high court on Monday heard oral arguments in a case backed by Democratic groups who...
Red Lobster Georgia restaurant locations closed temporarily
Atlanta Journal-Constitution· 1 day agoNews of the local closings comes days after Business Insider reported that Red Lobster is likely...
Q1 2024 Imunon Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoAnd as we reported this morning, enrollment has begun as promised in our Phase 1 vaccine study of immunized 101. A proof-of-concept trial to evaluate the immunization of patients against < ...
Fine dining, at a new high: Michelin-starred chef taking his cuisine to our upper atmosphere
Billings Gazette· 2 hours agoSix guests are set to ascend aboard Spaceship Neptune to the stratosphere, where they will enjoy an...
The carbon cost of return-to-office mandates
Crosscut· 4 hours agoMany companies made headway during the pandemic on promises to go green. Amazon employees in Seattle participate in a walkout to protest the company’s...
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
The Kansas City Star· 5 days agoXenetic Biosciences, Inc. (NASDAQ:XBIO) (”Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today reported its financial re...